Jason Ehrlich - Jun 15, 2021 Form 4 Insider Report for Kodiak Sciences Inc. (KOD)

Role
Chief Medical Officer and Chief Development Officer
Signature
/s/ David Peinsipp, Attorney-in-Fact for Jason Ehrlich
Stock symbol
KOD
Transactions as of
Jun 15, 2021
Transactions value $
-$117,624
Form type
4
Date filed
6/17/2021, 09:26 PM
Previous filing
Jun 15, 2021
Next filing
Jun 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KOD Common Stock Options Exercise +3.62K +5.57% 68.6K Jun 15, 2021 Direct F1
transaction KOD Common Stock Sale -$118K -1.45K -2.12% $80.90* 67.1K Jun 15, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KOD Restricted Stock Units Options Exercise $0 -3.62K -25% $0.00 10.9K Jun 15, 2021 Common Stock 3.62K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock.
F2 The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).
F3 One-fourth (1/4th) of the RSU vest on each of the first four anniversaries of June 15, 2020, subject to Reporting Person's continued service on the applicable vesting date.

Remarks:

Chief Medical Officer and Chief Development Officer